TK1 and Menkes disease: All previously reported FLT4 mutations in patients with MD were located in protein tyrosine kinase domains 1 or 2 (TK1 and TK2); exons 17–20 and 22–26, respectively) [7]; these mutations reduce tyrosine kinase activity and affect lymphatic development [12].